UK-414,495

http://dbpedia.org/resource/UK-414,495 an entity of type: Thing

UK-414,495 is a drug developed by Pfizer for the treatment of female sexual arousal disorder. UK-414,495 acts as a potent, selective inhibitor of the enzyme neutral endopeptidase, which normally serves to break down the neuropeptide VIP. The consequent increase in VIP activity alters blood flow to the genital region leading to increased lubrication and muscle relaxation. rdf:langString
rdf:langString UK-414,495
xsd:integer 26961555
xsd:integer 1073190032
xsd:integer 16
xsd:integer 337962
xsd:integer 378763
xsd:integer 8125410
xsd:integer 25
xsd:integer -2
xsd:integer 3
xsd:integer 3
xsd:integer 9949799
xsd:integer 1
rdf:langString CCC[C@H]CO
xsd:integer 1
rdf:langString FWXXCSISWQQOGS-LLVKDONJSA-N
rdf:langString JV29CG9MQ2
rdf:langString changed
xsd:integer 451558838
rdf:langString changed
rdf:langString UK-414,495 is a drug developed by Pfizer for the treatment of female sexual arousal disorder. UK-414,495 acts as a potent, selective inhibitor of the enzyme neutral endopeptidase, which normally serves to break down the neuropeptide VIP. The consequent increase in VIP activity alters blood flow to the genital region leading to increased lubrication and muscle relaxation.
xsd:nonNegativeInteger 3424
xsd:string 337962-93-3
xsd:string 378763
xsd:string JV29CG9MQ2
xsd:string 9949799

data from the linked data cloud